News

ExlService Holdings EXLS reported impressive first-quarter 2024 results, with both earnings and revenues beating the respective Zacks Consensus Estimate.

The stock has gained 2% since the release of earnings in response to the better-than-expected results and updated 2024 guidance. EXL raised the lower end of both revenue and EPS guidance range. Revenues are currently expected to be $1.79 to $1.82 billion compared with the previous guidance of $1.78 to $1.82 billion. The midpoint ($1.81 billion) of the updated guidance range is higher than the current Zacks Consensus Estimate of $1.8 billion.

The company currently expects EPS to be between $1.58 and $1.62 compared with the previous expectation of $1.56 to $1.62. The midpoint ($1.6) of the updated guidance range is slightly lower than the current Zacks Consensus Estimate of $1.61.

Quarterly adjusted EPS of 38 cents beat the consensus estimate by 5.6% and increased 8.6% on a year-over-year basis. Total revenues of $436.5 million beat the Zacks Consensus Estimate by 2.8% and increased 9% on a year-over-year basis on a reported currency basis and 8.8% on a constant currency basis.

Segmental Information

The Analytics segment contributed $190.7 million to total revenues, up 4.9% from the year-ago reported figure. The Insurance segment grew 15.2% from the year-ago figure to $145.1 million. Revenues generated from the Healthcare and Emerging Business segments were $26.3 million and $74.4 million, respectively.

Margins Increase

Adjusted EBITDA amounted to $91.7 million, up 6% year over year. Adjusted EBITDA margin on revenues was 21%, down 60 basis points year over year. Gross margin on total revenues came in at 37.4%, 20 basis points above the year-ago figure.

Key Balance Sheet Numbers

ExlService exited the quarter with cash and cash equivalents of $108.6 million, compared with $137 million at the end of the prior quarter. Long-term debt (net of current portion) was $280 million, compared with $135 million in the prior quarter.

Currently, EXL carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Recent Earnings Snapshots of Some Service Providers

Omnicom OMC reported impressive first-quarter 2024 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.

OMC’s earnings of $1.67 per share beat the consensus estimate by 9.9% and increased 7.1% year over year. Total revenues of $3.6 billion surpassed the consensus estimate by 1.6% and increased 5.4% year over year.

Equifax EFX reported mixed first-quarter 2024 results, wherein earnings surpassed the Zacks Consensus Estimate, but revenues missed the same.

EFX’s adjusted earnings were $1.5 per share, which beat the Zacks Consensus Estimate by 4.2% and up 4.9% from the year-ago quarter. Total revenues of $1.4 billion missed the consensus estimate by a slight margin but increased 6.7% from the year-ago quarter.

ManpowerGroup MAN reported mixed first-quarter 2024 results, with earnings beating the Zacks Consensus Estimate but revenues missing the same.

Quarterly adjusted earnings of 94 cents per share surpassed the consensus mark by 4.4% but declined 41.6% year over year. Revenues of $4.4 billion lagged the consensus mark by 0.6% and fell 7% year over year.

Buy 5 Stocks BEFORE Election Day

Biden or Trump? Zacks is releasing a FREE Special Report, Profit from the 2024 Presidential Election (no matter who wins).

Since 1950, presidential election years have been strong for the market. This report names 5 timely stocks to ride the wave of electoral excitement.

They include a medical manufacturer that gained +11,000% in the last 15 years… a rental company absolutely crushing its sector… an energy powerhouse planning to grow its already large dividend by 25%... an aerospace and defense standout that just landed a potentially $80 billion contract… and a giant chipmaker building huge plants in the U.S.

Don’t Wait. Download FREE >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.